@article{10.11648/j.ijcu.20220602.12,
  author = {Muftau Jimoh Bioku and Ayoleke Ogunrinde and Emmanuel Ugwu and Olatunde Olawoye and Izuchukwu Benerdin Achusi and Quadri Sanni and Ahmed Saad Aliyu},
  title = {Efficacy and Safety Outcomes of Monopolar Transurethral Resection of the Prostate in Abuja, Nigeria},
  journal = {International Journal of Clinical Urology},
  volume = {6},
  number = {2},
  pages = {71-75},
  doi = {10.11648/j.ijcu.20220602.12},
  url = {https://doi.org/10.11648/j.ijcu.20220602.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcu.20220602.12},
  abstract = {Introduction: Benign prostatic hyperplasia (BPH) is the most common disease in older men. Its clinical manifestations as lower urinary tract symptoms (LUTS) negatively impact patients’ quality of life. Transurethral resection of prostate (TURP) has held a unique position as the front-line endoscopic treatment of BPH for many decades in developed nations. However, there are few literatures on its use in this environment. Objective: To document the 5-year efficacy and safety outcome of monopolar TURP for the treatment of the LUTS secondary to BPH at Federal Medical Centre (FMC), Abuja. Patients and Methods: A retrospective study of all men who had monopolar TURP with histologic confirmation of BPH between June 2016 and May 2021. The information retrieved includes age, prostate specific antigen (PSA), preoperative and postoperative International Prostate Symptom Score (IPSS), ultrasound prostatic weight, post-void residual (PVR), indications for TURP, operation time, postoperative complications, and histological reports. These data were analyzed using SPSS version 27.0. Results: A total of 142 patients who had M-TURP met the inclusion criteria. The age range was 49-88 years with a mean of 66.04 years. The mean Prostatic weight was 61.27g (range 21-81g) while serum PSA ranged from 1.0 to 10.1ng/ml (mean = 3.73 ng/ml). The average operation time was 59.29 minutes (range= 46-73 minutes). The most common indication for TURP was recurrent acute urinary retention (n=65,45.8%) while bleeding is the leading complication (n=9, 6.3%). There was no TUR syndrome or intraoperative death. However, the transfusion rate was 6.3%. We recorded improvements in IPSS from 21.53 to 3.43. Histological reports revealed BPH only in 82.4% of cases (n= 117) and BPH with prostatitis in 17.6%(n=25). Conclusions: With appropriate patient selection and organized resection technique, monopolar TURP is a feasible, safe and effective surgical option in the management of BPH-related LUTS.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Efficacy and Safety Outcomes of Monopolar Transurethral Resection of the Prostate in Abuja, Nigeria
AU  - Muftau Jimoh Bioku
AU  - Ayoleke Ogunrinde
AU  - Emmanuel Ugwu
AU  - Olatunde Olawoye
AU  - Izuchukwu Benerdin Achusi
AU  - Quadri Sanni
AU  - Ahmed Saad Aliyu
Y1  - 2022/07/28
PY  - 2022
N1  - https://doi.org/10.11648/j.ijcu.20220602.12
DO  - 10.11648/j.ijcu.20220602.12
T2  - International Journal of Clinical Urology
JF  - International Journal of Clinical Urology
JO  - International Journal of Clinical Urology
SP  - 71
EP  - 75
PB  - Science Publishing Group
SN  - 2640-1355
UR  - https://doi.org/10.11648/j.ijcu.20220602.12
AB  - Introduction: Benign prostatic hyperplasia (BPH) is the most common disease in older men. Its clinical manifestations as lower urinary tract symptoms (LUTS) negatively impact patients’ quality of life. Transurethral resection of prostate (TURP) has held a unique position as the front-line endoscopic treatment of BPH for many decades in developed nations. However, there are few literatures on its use in this environment. Objective: To document the 5-year efficacy and safety outcome of monopolar TURP for the treatment of the LUTS secondary to BPH at Federal Medical Centre (FMC), Abuja. Patients and Methods: A retrospective study of all men who had monopolar TURP with histologic confirmation of BPH between June 2016 and May 2021. The information retrieved includes age, prostate specific antigen (PSA), preoperative and postoperative International Prostate Symptom Score (IPSS), ultrasound prostatic weight, post-void residual (PVR), indications for TURP, operation time, postoperative complications, and histological reports. These data were analyzed using SPSS version 27.0. Results: A total of 142 patients who had M-TURP met the inclusion criteria. The age range was 49-88 years with a mean of 66.04 years. The mean Prostatic weight was 61.27g (range 21-81g) while serum PSA ranged from 1.0 to 10.1ng/ml (mean = 3.73 ng/ml). The average operation time was 59.29 minutes (range= 46-73 minutes). The most common indication for TURP was recurrent acute urinary retention (n=65,45.8%) while bleeding is the leading complication (n=9, 6.3%). There was no TUR syndrome or intraoperative death. However, the transfusion rate was 6.3%. We recorded improvements in IPSS from 21.53 to 3.43. Histological reports revealed BPH only in 82.4% of cases (n= 117) and BPH with prostatitis in 17.6%(n=25). Conclusions: With appropriate patient selection and organized resection technique, monopolar TURP is a feasible, safe and effective surgical option in the management of BPH-related LUTS.
VL  - 6
IS  - 2
ER  - 

Copy | Download